Use access key #2 to skip to page content.

IBDvalueinvestin (98.36)

DDSS Billion $$$ Drug Potential set for FDA Approval Decision late next week.



July 07, 2009 – Comments (0) | RELATED TICKERS: DDSS.DL22

Labopharm (NASDAQ:DDSS): A decision date of 7/18/09 is looming for the Company's rapid-onset formulation of trazodone (DDS-04A) for the treatment of depression through the 505(b)(2) regulatory pathway for new formulations drugs that are already on the market.


0 Comments – Post Your Own

Featured Broker Partners